Renoprotective Effect of Yiqi Yangyin Huayu Tongluo Formula against Diabetic Nephropathy in Diabetic Rats

Author:

Wang Feng-li1,Wang Yue-hua2,Han Lin3ORCID,An Hai-yan4,Zhang Jiang-hua5,Zhang Xue-yun5,Chen Zhi-qiang6ORCID,Qin Jian-guo4ORCID

Affiliation:

1. Central Laboratory, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing 100078, China

2. Department of Nephropathy, Hebei Medical University Third Hospital, Shijiazhuang, Hebei 050081, China

3. School of Basic Medicine, Beijing University of Chinese Medicine, Beijing 100029, China

4. Department of Nephropathy, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing 100078, China

5. School of Integrated Traditional Chinese and Western Medicine, Hebei Medical University, Shijiazhuang, Hebei 050017, China

6. Department of Nephropathy, Hebei Provincial Hospital of Traditional Chinese Medicine, Shijiazhuang, Hebei 050017, China

Abstract

Diabetic nephropathy is developed in 20-40% of patients with diabetes mellitus, and patients with diabetic nephropathy require dialysis and renal transplantation. Traditional Chinese medicine has been widely used in treating patients with diabetic nephropathy in China. However, the detailed mechanisms of traditional Chinese medicine remain unclear. Yiqi Yangyin Huayu Tongluo formula (ZY formula) is a traditional Chinese medicinal formula. Here, we demonstrated kidney protective effect of ZY formula on the rats with diabetic nephropathy. The therapeutic effect of ZY formula on the diabetic nephropathy was almost the same as that of Irbesartan, which proved to have excellent curative effects on diabetic nephropathy. We also demonstrated the mechanism of ZY formula effect on the diabetic nephropathy. First, we validated that the activation of ROS-JNK signaling pathway in diabetic rats could be reduced by ZY. Furthermore, collagen I expression could be downregulated by ZY formula treatment. Meanwhile, cell apoptosis in the kidney of diabetic rats could be alleviated by ZY formula.

Funder

National Natural Science Foundation of China

Publisher

Hindawi Limited

Subject

Complementary and alternative medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3